Self-Injury
8
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Extensions of Resurgence as Choice
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Pilot Trial of an Emotion Regulation and Executive Functioning Intervention for Self-Injurious Thoughts and Behaviors (SITBs) in Children
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
Manualized Assessment and Treatment Model of Challenging Behavior
Resurgence as Choice: Basic and Clinical Studies
Treating Self Injurious Behavior: A Novel Brain Stimulation Approach
Rapalogues for Autism Phenotype in TSC: A Feasibility Study